Differentiation and CD2 3 expression of peripheral blood monocytes in patients with atopic dermatitis
- 29 July 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 133 (5), 757-763
- https://doi.org/10.1111/j.1365-2133.1995.tb02751.x
Abstract
In this study we investigate the expression of the low affinity immunoglobulin E (IgE) receptor (Fc epsilon RII) on plastic-adherent leucocytes from patients with atopic dermatitis (AD). Peripheral blood mononuclear cells were obtained from patients with AD, normal controls (and in one study from a group of atopic asthmatic patients). Monocytes were separated by 2-h adherence to plastic. These cells were then cultured for up to 7 days. Cells were harvested at time 0 (after adherence), and after 5 and 7 days culture, and cytospins were prepared. The proportion of cells expressing the phenotype of antigen presenting cells (monoclonal antibodies (mAb) RFD1+), and mature phagocytes (mAb RFD7+) together with CD23, were evaluated using combination staining with immunoperoxidase and alkaline phosphatase anti-alkaline phosphatase methods. It was found that a significantly larger proportion of circulating adherent cells in AD patients expressed the RFD1 antigen, and that increases in the proportion of these adherent cells expressing RFD1 or RFD7 occurred faster as cells matured in culture, when compared with cells obtained from normal controls. By day 7, however, equivalent proportions of RFD1+ and RFD7+ cells were present in AD and control cultures. None the less, expression of the CD23 molecule was consistently present on a larger proportion of both RFD1+ and RFD7+ cells from AD patients compared with controls. The raised proportion of circulating RFD1+ cells found in AD was not present in samples from atopic asthmatics, while the raised expression of CD23 on these cells occurred in samples from both these groups. These data support the suggestion that abnormalities in peripheral blood adherent cell phenotype, maturation, and CD23 expression, occur in AD patients. Some of these observations may be related to atopy in general rather than being specific for this skin disease.Keywords
This publication has 20 references indexed in Scilit:
- CD23/FcεR11 expression in contact sensitivity reactions: a comparison between aeroallergen patch test reactions in atopic dermatitis and the nickel patch test reaction in non-atopic individualsClinical and Experimental Immunology, 1993
- FcεRI Mediates IgE-Binding to Human Epidermal Langerhans CellsPublished by Springer Nature ,1993
- Fcε receptor II/CD23+ lymphocytes in atopic dermatitis. III. Aberrant control in thein vitroexpression of FcεRII/CD23 on peripheral blood T cells in atopic dermatitisClinical and Experimental Immunology, 1992
- Gamma-Interferon Promotes the Release of IgE-Binding Factors (Soluble CD23) by Human Epidermal Langerhans CellsJournal of Investigative Dermatology, 1991
- Characterization of immune inducer and suppressor macrophages from the normal human lungClinical and Experimental Immunology, 1991
- Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon.The Journal of Experimental Medicine, 1989
- Two species of human Fcε receptor II ( ): Tissue-specific and IL-4-specific regulation of gene expressionCell, 1988
- Discrimination of Human Macrophages and Dendritic Cells by Means of Monoclonal AntibodiesScandinavian Journal of Immunology, 1986
- The receptor for IgE on blood plateletsEuropean Journal of Immunology, 1986
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984